François Eyskens

916 total citations
17 papers, 292 citations indexed

About

François Eyskens is a scholar working on Physiology, Epidemiology and Neurology. According to data from OpenAlex, François Eyskens has authored 17 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 4 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in François Eyskens's work include Lysosomal Storage Disorders Research (10 papers), Trypanosoma species research and implications (3 papers) and Metabolism and Genetic Disorders (3 papers). François Eyskens is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Trypanosoma species research and implications (3 papers) and Metabolism and Genetic Disorders (3 papers). François Eyskens collaborates with scholars based in Belgium, United Kingdom and United States. François Eyskens's co-authors include Robert J. Baker, Peter Paul De Deyn, Raf Brouns, Derralynn Hughes, Marie‐Françoise Vincent, Vincent Thijs, Shibeshih Belachew, Marleen Van den Broeck, Dimitri Hemelsoet and Sandrine Jeangette and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

François Eyskens

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Eyskens Belgium 8 153 72 70 65 54 17 292
Chuan‐Hong Kao Taiwan 7 204 1.3× 158 2.2× 39 0.6× 102 1.6× 68 1.3× 10 411
Emma Glamuzina New Zealand 11 68 0.4× 148 2.1× 62 0.9× 76 1.2× 61 1.1× 30 323
David F. Kronn United States 7 114 0.7× 156 2.2× 35 0.5× 62 1.0× 23 0.4× 9 310
Surekha Pendyal United States 9 128 0.8× 89 1.2× 121 1.7× 214 3.3× 25 0.5× 21 366
E. Mutel France 7 146 1.0× 165 2.3× 64 0.9× 100 1.5× 14 0.3× 7 369
Vladimı́r Bzdúch Slovakia 8 83 0.5× 103 1.4× 39 0.6× 42 0.6× 26 0.5× 28 259
Suresh Vijay United Kingdom 9 252 1.6× 68 0.9× 25 0.4× 79 1.2× 40 0.7× 31 337
Michelina Sibilio Italy 11 86 0.6× 88 1.2× 43 0.6× 88 1.4× 10 0.2× 19 253
Kristiane Michelin‐Tirelli Brazil 11 288 1.9× 98 1.4× 25 0.4× 43 0.7× 17 0.3× 23 347
Veronica Ileana Guerci Italy 7 109 0.7× 82 1.1× 108 1.5× 58 0.9× 8 0.1× 10 288

Countries citing papers authored by François Eyskens

Since Specialization
Citations

This map shows the geographic impact of François Eyskens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Eyskens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Eyskens more than expected).

Fields of papers citing papers by François Eyskens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Eyskens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Eyskens. The network helps show where François Eyskens may publish in the future.

Co-authorship network of co-authors of François Eyskens

This figure shows the co-authorship network connecting the top 25 collaborators of François Eyskens. A scholar is included among the top collaborators of François Eyskens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Eyskens. François Eyskens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Verhulst, Stijn, et al.. (2024). Unexplained splenomegaly as a diagnostic marker for a rare but severe disease with an innovative and highly effective new treatment option: A case report. Molecular Genetics and Metabolism Reports. 41. 101144–101144. 1 indexed citations
2.
Holida, Myrl, Aleš Linhart, Antonio Pisani, et al.. (2024). A phase III, open‐label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies. Journal of Inherited Metabolic Disease. 48(1). e12795–e12795. 6 indexed citations
3.
Roosens, Laurence, et al.. (2023). A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry. Molecular Genetics and Metabolism Reports. 37. 100993–100993. 4 indexed citations
4.
Jonckheere, An I., Sandra D.K. Kingma, François Eyskens, Victoria Bordon, & Anna Jansen. (2023). Metachromatic leukodystrophy: To screen or not to screen?. European Journal of Paediatric Neurology. 46. 1–7. 1 indexed citations
5.
Bernat, John, Myrl Holida, Nicola Longo, et al.. (2023). Long-term safety and efficacy of pegunigalsidase alfa administered every 4 weeks in patients with Fabry disease: Two-year interim results from the ongoing phase 3 BRIGHT51 open-label extension study. Molecular Genetics and Metabolism. 138(2). 107027–107027. 2 indexed citations
6.
Eyskens, François, et al.. (2017). Newborn Screening for Lysosomal Storage Disorders in Belgium. SHILAP Revista de lepidopterología. 5. 4078186583–4078186583. 7 indexed citations
7.
Eyskens, François, et al.. (2015). Epidemiological data on sickle cell disease in Belgium. Open Repository and Bibliography (University of Liège). 2 indexed citations
8.
Vandevijvere, Stefanie, Wim Coucke, Jean Vanderpas, et al.. (2012). Neonatal Thyroid-Stimulating Hormone Concentrations in Belgium: A Useful Indicator for Detecting Mild Iodine Deficiency?. PLoS ONE. 7(10). e47770–e47770. 39 indexed citations
9.
Brouns, Raf, Vincent Thijs, François Eyskens, & Peter Paul De Deyn. (2010). Response to Letter Regarding Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease. Stroke. 42(1). 2 indexed citations
10.
Brouns, Raf, Vincent Thijs, François Eyskens, et al.. (2010). Belgian Fabry Study. Stroke. 41(5). 863–868. 82 indexed citations
11.
Brouns, Raf, François Eyskens, K. De Boeck, et al.. (2009). Fabry disease in a patient with Turner syndrome. Journal of Inherited Metabolic Disease. 32(S1). 45–48. 3 indexed citations
12.
Brouns, Raf, Rishi Sheorajpanday, François Eyskens, et al.. (2007). Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. Clinical Neurology and Neurosurgery. 109(6). 479–484. 47 indexed citations
13.
Roels, Frank, Patrick Verloo, Sara Seneca, et al.. (2006). Mitochondrial mosaics in the liver of patients with Pearson and Alpers-Huttenlocher syndromes.. Ghent University Academic Bibliography (Ghent University). 29. 119–119.
14.
Eyskens, François, et al.. (2006). Cognitive functioning and psychiatric disorders in children with a metabolic disease. European Child & Adolescent Psychiatry. 15(4). 207–213. 9 indexed citations
15.
Eyskens, François & Elise M. Philips. (2006). G.P.10 10 Newborn screening for Duchenne muscular dystrophy. The experience in the province of Antwerp. Neuromuscular Disorders. 16(9-10). 721–721. 10 indexed citations
16.
Rooms, Liesbeth, Edwin Reyniers, Wim Wuyts, et al.. (2005). Multiplex ligation‐dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clinical Genetics. 69(1). 58–64. 51 indexed citations
17.
Eyskens, François, et al.. (1994). Carbohydrate‐deficient glycoprotein syndrome with previously unreported features. Acta Paediatrica. 83(8). 892–896. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuan‐Hong Kao Breakdown of academic impact, for papers by Emma Glamuzina Breakdown of academic impact, for papers by David F. Kronn Breakdown of academic impact, for papers by Surekha Pendyal Breakdown of academic impact, for papers by E. Mutel Breakdown of academic impact, for papers by Vladimı́r Bzdúch Breakdown of academic impact, for papers by Suresh Vijay Breakdown of academic impact, for papers by Michelina Sibilio Breakdown of academic impact, for papers by Kristiane Michelin‐Tirelli Breakdown of academic impact, for papers by Veronica Ileana Guerci
Rankless by CCL
2026